The hMSCs from bone marrow are key players in bone homeostasis and serve as an optimal in vitro model for studying XT-I deficiency due to their differentiation potential into osteoblasts, chondrocytes, and adipocytes [22,23]. The gene discussed is XYLT1; the disease is hyperinsulinemic hypoglycemia, familial, 4.